[1]Everson GT, Helmke SM, Doctor B.Advances inmanagement of polycystic liver disease[J].Expert RevGastroenterol Hepatol, 2008, 2 (4) :563-576.
|
[2]Shneider BL, Magid MS.Liver disease in autosomal recessivepolycystic kidney disease[J].Pediatr Transpl, 2005, 9 (5) :634-639.
|
[3]Torres VE, Harris PC.Autosomal dominant polycystic kidneydisease:the last 3 years[J].Kidney Int, 2009, 76 (2) :149-168.
|
[4]Masyuk T, Masyuk A, LaRusso N.Cholangiociliopathies:genetics, molecular mechanisms and potential therapies[J].Curr Opin Gastroenterol, 2009, 25 (3) :265-271.
|
[5]Fencl F, Janda J, Blahova K, et al.Genotype-phenotypecorrelation in children with autosomal dominant polycystickidney disease[J].Pediatr Nephrol, 2009, 24 (5) :983-989.
|
[6]江雨, 周裕林.常染色体隐性遗传性多囊肾病 (ARPKD) 基因缺陷的研究进展[J].中国优生与遗传学杂志, 2007, 15 (2) :114-115.
|
[7]Masyuk AI, Masyuk TV, LaRusso NF.Cholangiocyteprimary cilia in liver health and disease[J].Dev Dyn, 2008, 237 (8) :2007-2012.
|
[8]Torrice A, Cardinale V, Gatto M, et al.Polycystins play a keyrole in the modulation of cholangiocyte proliferation[J].DigLiver Dis, 2010, 42 (5) :377-385.
|
[9]Muchatuta MN, Gattone VH 2nd, Witzmann FA, et al.Structural and functional analyses of liver cysts from theBALB/c-cpk mouse model of polycystic kidney disease[J].Exp Biol Med (Maywood) , 2009, 234 (1) :17-27.
|
[10]Alvaro D, Onori P, Alpini G, et al.Morphological andfunctional features of hepatic cyst epithelium in autosomaldominant polycystic kidney disease[J].Am J Pathol, 2008, 172 (2) :321-332.
|
[11]Nishio S, Hatano M, Nagata M, et al.Pkd1 regulatesimmortalized proliferation of renal tubular epithelial cellsthrough p53 induction and JNK activation[J].J Clin Invest, 2005, 115 (4) :910-918.
|
[12]Brodsky KS, McWilliams RR, Amura CR, et al.Livercyst cytokines promote endothelial cell proliferationand development[J].Exp Biol Med (Maywood) , 2009, 234 (10) :1155-1165.
|
[13]Fabris L, Cadamuro M, Fiorotto R, et al.Effects of angiogenicfactor overexpression by human and rodent cholangiocytesin polycystic liver diseases[J].Hepatology, 2006, 43 (5) :1001-1012.
|
[14]Spirli C, Okolicsanyi S, Fiorotto R, et al.ERK1/2-dependentvascular endothelial growth factor signaling sustains cystgrowth in polycystin-2 defective mice[J].Gastroenterology, 2010, 138 (1) :360-371.
|
[15]Glaser SS, Gaudio E, Miller T, et al.Cholangiocyteproliferation and liver fibrosis[J].Expert Rev Mol Med, 2009, 11:e7.
|
[16]Keimpema LV, Nevens F, Vanslembrouck R, et al.Lanreotidereduces the volume of polycystic liver:A randomized, double-blind, placebo-controlled trial[J].Gastroenterology, 2009, 137 (5) :1661-1668.
|
[17]Wang S, Zhang J, Nauli SM, et al.Fibrocystin/polyductin, found in the same protein complex with polycystin-2, regulates calcium responses in kidney epithelia[J].Mol CellBiol, 2007, 27 (8) :3241-3252.
|
[18]Banales JM, Masyuk TV, Gradilone SA, et al.The cAMPeffectors Epac and protein kinase a (PKA) are involved inthe hepatic cystogenesis of an animal model of autosomalrecessive polycystic kidney disease (ARPKD) [J].Hepatology, 2009, 49 (1) :160-174.
|
[19]Amura CR, Brodsky KS, Gitomer B, et al.CXCR2 agonistsin ADPKD liver cyst fluids promote cell proliferation[J].Am JPhysiol Cell Physiol, 2008, 294 (3) :C786-C796.
|
[20]Lai X, Blazer-Yost BL, Gattone VH 2nd, et al.Proteincomposition of liver cyst fluid from the BALB/c-cpk/+mousemodel of autosomal recessive polycystic kidney disease[J].Proteomics, 2009, 9 (14) :3775-3782.
|
[21]Masyuk T, Masyuk A, LaRusso N.MicroRNAs incholangiociliopathies[J].Cell Cycle, 2009, 8 (9) :1324-1328.
|